Tissue-Engineered Skin Substitutes Using Collagen Scaffold with Amniotic Membrane Component


Article Preview

Human skin substitutes are needed for implantation and wound repair based on the new concept of tissue engineering in combination with biomaterials and cell biological technology. However, failure sometimes occurs when the wound healing is delayed in vivo due to acute inflammation resulting from the early degradation of the transplanted biomaterials. Accordingly, the current study modified conventional biomaterials to overcome early degradation and strong inflammation. In a conventional skin substitute, the animal origin collagenous materials have a slight antigenicity as xenogenic materials, however, the modified method was able to obtain a low antigenicity and anti-inflammation effect using atelo-collagen and an amniotic component. The tyrosine content in the developed atelo-collagen, representing the antigenicity, was reduced from 0.590% to 0.046% based on an HPLC analysis. In addition, to reduce the inflammation and foreign material reaction, an amniotic component was applied to the atelo-collagen materials. While, to enhance the wound healing, the modified skin substitute was developed as a composite matrix of an atelo-collagen scaffold with an amniotic membrane component. A quantitative analysis of hEGF in the amniotic membrane was also performed using different processing methods. Finally, a tissueengineered skin substitute was constructed by cultivating skin cells in the collagen scaffold attached to an amniotic membrane.



Key Engineering Materials (Volumes 277-279)

Edited by:

Kwang Hwa Chung, Yong Hyeon Shin, Sue-Nie Park, Hyun Sook Cho, Soon-Ae Yoo, Byung Joo Min, Hyo-Suk Lim and Kyung Hwa Yoo




E. K. Yang et al., "Tissue-Engineered Skin Substitutes Using Collagen Scaffold with Amniotic Membrane Component ", Key Engineering Materials, Vols. 277-279, pp. 12-18, 2005

Online since:

January 2005




[1] R. Langer, J.P. Vacanti, Tissue engineering. Science Vol. 260 (1993), pp.920-924.

[2] J.F. Burke, I.V. Yannas, W.C. Quinby, C.C. Bondoc, W.K. Jung, Successful use of a physiologically acceptible artificial skin in the treatment of extensive burn injury. Ann Surg Vol. 194 (1981), pp.413-428.

DOI: https://doi.org/10.1097/00000658-198110000-00005

[3] J.T. Tyszkiewicz, I.A. Uhrynowska- Tyszkiewicz, A. Kaminski, A. Dziedzic-Goclawska, Amnion allografts prepared in the Central Tissue Bank in Warsaw, Annals of Transplantation, Vol. 4-3 (1999), pp.85-90.

[4] E.K. Yang, D.H. Lee, S.N. Park, J.K. Park, Tissue engineered artificial skin composed of dermis and epidermis, Artificial Organs, Vol. 24-1 (2000), pp.7-17.

DOI: https://doi.org/10.1046/j.1525-1594.2000.06334.x

[5] E.K. Yang, H.H. Yoon, D.H. Lee, J.K. Park, Assessment of Toxic Potential of Industrial Chemicals using Cultured Human Bioartificial Skin Model: Production of Interleukin-1α and Hydroxyeicosatetraenoic acids, Skin Pharmacology and Applied Skin Physiology, Vol. 13-5 (2000).

DOI: https://doi.org/10.1159/000029930

[6] E.K. Yang, Y.K. Seo, J.K. Park, Development and Application of Bioartificial Skin (Editor Review) International Jounal of Artificial Organs Vol. 23-9 (2000), pp.597-600.

[7] E.K. Yang, Y.K. Seo, J.K. Park, Reinforced bioartificial skin in the form of collagen sponge and threads", Forcus on Biotechnology, Novel Frontiers in the Production of Compounds for Biomedical Use, Kluwer Academic Publishers Vol. 1 (2001).

DOI: https://doi.org/10.1007/0-306-46885-9_22